Abstract: A curing process includes providing a hybrid material comprising a conductive filler in contact with a thermosetting resin. In addition, the curing process includes passing an electric current through the hybrid material to provide Joule heating until a temperature of the hybrid material reaches a temperature above a curing temperature of the thermosetting resin.

Abstract: Provided herein are in situ generated conformationally constrained peptide arrays, methods for synthesizing such arrays, and methods, systems and assays comprising the use of the synthesized constrained peptide arrays for characterizing protein-target Interactions including: antibody-target interactions, receptor agonist interactions, receptor antagonist interactions, enzyme substrate interactions, enzyme inhibitor interactions, and other protein-protein interactions.

Abstract: Systems and methods for enhancing hydraulic fracturing productivity for recovery of a reservoir fluid from a reservoir formation having an open fracture includes providing a shape memory filter that is pseudoelastically deformed and contained within a soluble container. The shape memory filter and soluble container are pumped into the open fracture so that the soluble container dissolves and the shape memory filter returns to an expanded filter shape. A proppant is pumped into the open fracture so that the proppant is trapped by the shape memory filter and forms a column across the open fracture.

Abstract: A method is provided for making a silicided gate in a semiconductor device. In accordance with the method, a gate (213) is provided which comprises a first portion (214) and a second portion (213). The first portion of the gate has a width w1 and the second portion of the gate has a width w2 as taken along a plane perpendicular to the length of the gate, wherein w2>w1. A layer is silicide (231) is then formed on the second portion.

Abstract: This invention relates to a novel inhibitor of beta amyloid cleavage enzyme (BACE, transmembrane aspartyl protease beta-secretase, beta site APP cleavage enzyme, memapsin-2, BACE-1), pharmaceutical compositions containing it and its use in the treatment of neurological disorders such as Alzheimer's disease, Crutzfield-Jacob's disease, prion disorders, amyotrophic lateral sclerosis, progressive supranuclear palsy, head trauma, stroke, down's syndrome, pancreatitis, inclusion body myocitis, other peripheral amyloidoses and diabetes.